Article Information
History
- July 26, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ang Li1,2,*,
- Yi Zi1,2,
- Jiaqi Luo1,2,
- Xiaobin You1,2,
- Zhaoji Lan1,2,
- Tianliangwen Zhou1,
- Yangming Wu1,
- Qihuan Zhi1,
- Huijun Su1,
- Mei Zhu1,
- Siwen Xu1,
- Yun Gao1,
- Zaixuan Zhong1,
- Ling Xie1,
- Yuanqin Wang1,
- Qiuping Lin1,
- Xiaoting Li1,
- Jiamin Zhan1,
- Hui Weng1,
- Dan Li1,
- Shulan Xu1,
- Gang Sun1 and
- Yujian Shi1,*
- ↵*To whom correspondence should be addressed: Ang Li, liang0346{at}gmail.com, Yujian Shi, yujian.shi{at}topgene.cn
↵2 These authors contributed equally to this work.
Posted July 26, 2020.
Assessing the variations in breast/ovarian cancer risk for Chinese BRCA1/2 carriers
